From: Risk prediction of biomarkers for early multiple organ dysfunction in critically ill patients
 | AUC(95%CI) | Improvement of AUC | P-value | NRI (95%CI) | P-value | Sensitivity | Specificity | PPV | NPV |
---|---|---|---|---|---|---|---|---|---|
qSOFA (Day-0) | 0.728 (0.651–0.794) |  |  |  | 64.2 | 66.2 | 73.5 | 55.8 | |
qSOFA (Day-0) + IL-6(Day-0) | 0.765 (0.685–0.830) | 0.037 (0.001–0.073) | 0.252 | 0.562 (0.267–0.857) | 0.001* | 83.2 | 56.9 | 73.8 | 69.8 |
qSOFA (Day-0) + IL-6(Day-1) | 0.842 (0.771–0.893) | 0.113 (0.053–0.174) | 0.002* | 0.802 (0.520–1.084) | < 0.001* | 74.7 | 86.2 | 88.8 | 70.0 |
qSOFA (Day-0) + PCT (Day-0) | 0.814 (0.740–0.870) | 0.086 (0.033–0.138) | 0.008* | 0.661 (0.362–0.959) | < 0.001* | 82.1 | 64.6 | 77.2 | 71.2 |
qSOFA (Day-0) + PCT (Day-1) | 0.785 (0.707–0.847) | 0.057 (0.011–0.103) | 0.084 | 0.492 (0.188–0.797) | 0.009* | 67.4 | 76.9 | 81.0 | 61.7 |
qSOFA (Day-0) + IL-8(Day-0) | 0.793 (0.716–0.854) | 0.061 (0.016–0.105) | 0.044* | 0.502 (0.198–0.806) | 0.007* | 78.9 | 67.2 | 78.1 | 68.3 |
qSOFA (Day-0) + IL-8(Day-1) | 0.829 (0.758–0.882) | 0.100 (0.045–0.155) | 0.002* | 0.784 (0.494–1.073) | < 0.001* | 71.6 | 78.5 | 82.9 | 65.4 |
qSOFA (Day-1) | 0.801 (0.723–0.861) |  |  |  | 58.1 | 83.1 | 83.1 | 58.1 | |
qSOFA (Day-1) + IL-6(Day-1) | 0.868 (0.799–0.915) | 0.067 (0.025–0.108) | 0.005* | 0.712 (0.423–1.001) | < 0.001* | 89.2 | 70.8 | 81.4 | 82.1 |
qSOFA (Day-1) + PCT (Day-1) | 0.842 (0.765–0.897) | 0.041 (0.009–0.073) | 0.037* | 0.503 (0.201–0.805) | 0.003* | 78.5 | 80.0 | 84.9 | 72.2 |
qSOFA (Day-1) + IL-8(Day-1) | 0.881 (0.816–0.925) | 0.080 (0.039–0.121) | < 0.001* | 0.718 (0.423–1.013) | < 0.001* | 92.5 | 69.2 | 81.1 | 86.5 |